ALFA Filings
Every announcement, straight from the exchange
Every Aurobindo Pharma other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
2 announcements with these filters
Aurobindo Pharma Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as mandated by SEBI regulations.
Aurobindo Pharma dispatched letters to shareholders without registered email IDs. These letters provide a web link to the Integrated Annual Report 2025-26.